The chemical properties of iron, which make it both malleable and strong, have shaped human history. Nature itself uses the flexible chemistry of iron in many crucial metabolic reactions, such as the synthesis of ATP and DNA. Due to the role of iron in cellular proliferation, iron chelators are agents that may be useful for the treatment of cancer (for review see Richardson [2005] ). Hence, a comprehensive knowledge of iron metabolism is essential for understanding basic biological processes such as growth and organogenesis.
The study of iron metabolism can be roughly divided into "old" and "new" iron ages. The literature of the old iron age teaches that iron is first bound by transferrin, the serum iron transport molecule. Iron bound transferrin binds to the transferrin receptor-1 (TfR1), which is then internalized by receptor-mediated endocytosis (Richardson, 2005) . Iron is released from transferrin by low endosomal pH and transported across the membrane and into the cell where it is incorporated into the iron-storage protein, ferritin. The relative levels of TfR1 and ferritin are regulated posttranscriptionally by iron, at least in part through iron-regulatory proteins 1 and 2.
In the past decade, we have witnessed a new iron age with the remarkable discovery of additional molecules that play crucial roles in iron metabolism. These proteins include the hemochromatosis gene product (HFE), the divalent metal transporter-1 (DMT1), transferrin receptor-2, hephaestin, ferroportin-1, hepcidin and hemojuvelin (Richardson, 2005) . As part of the new iron age, recent attention also has focused on the lipocalin 24p3 (also called lipocalin-2 or uterocalin in mice and neutrophil-gelatinase-associated lipocalin [NGAL] in humans). Lipocalins are small secreted proteins that bind to low-molecular-weight ligands and play roles in many processes including olfaction, retinol transport, and prostaglandin synthesis. In this issue of Cell, Green and colleagues (Devireddy et al., 2005) describe the cloning of the receptor for 24p3 called 24p3R. The DNA sequence of this molecule matched a database entry proposed to encode a murine braintype organic cation transporter (NM_ 021551). This molecule is highly conserved in humans and is predicted to have twelve transmembrane helices. The authors suggest a link between iron internalization mediated by 24p3R and the regulation of apoptosis.
As a strategy against infection, mammalian cells sequester iron to prevent it from being used for bacterial growth. Several lipocalins (lipocalin-1 and 24p3) bind to iron through the ligation of bacterial catecholate and mycobacterial siderophores (smallmolecular-weight chelators) such as enterobactin Flo et al., 2004; Fluckinger et al., 2004; Holmes et al., 2005) . Lipocalin-1 and 24p3 act during the acute phase of the innate immune response (Flo et al., 2004) and bolster the defense provided by transferrin and lactoferrin, which bind to "free iron." Interestingly, mice lacking 24p3 display no phenotype under pathogen-free conditions, but upon exposure to sublethal doses of Escherichia coli H9049, these 24p3-deficient mice were far more likely to develop bacteremia (Flo et al., 2004) .
In addition to the role of lipocalin-1 and 24p3 in innate immunity, it has also been reported that 24p3 is involved in kidney development as an iron-donating molecule (Yang et al., 2002) . Intriguingly, 24p3 was originally purified as a protein that promotes the mesenchymal to epithelial conversion of ureteric bud cell lines. This effect could potentially be related to the ability of 24p3 to donate iron to cells (Yang et al., 2003) . It was suggested that 24p3 could bind to iron and then deliver it to the cell through a process requiring endocytosis and endosomal acidification, although this pathway differed from that used by transferrin (Yang et al., 2002) . Furthermore, 24p3 may be taken up by primordial epithelial and stromal cells, whereas transferrin is internalized by later-stage epithelial cells (Yang et al., 2002) . This led to the proposal that 24p3 may be an iron donor, independent of 24p3 and Its Receptor: Dawn of a New Iron Age?
24p3 is a secreted protein that induces apoptosis in leukocytes. Recently, 24p3 has been shown to bind to iron-containing bacterial siderophores. In this issue of Cell, Devireddy et al. (2005) identify a receptor that internalizes 24p3. Internalization of iron bound to 24p3 prevents apoptosis. In contrast, internalization of the apo form of 24p3 that does not contain iron leads to cellular iron efflux and apoptosis via the proapoptotic protein Bim.
the transferrin-TfR1 pathway, which is vital for early embryonic development (Levi et al., 1999) .
A link has been established between apoptosis and the level of iron within the cell (Richardson, 2005) , and intriguing results have implicated 24p3 in apoptosis (Devireddy et al., 2001) . It is well known that apoptosis can be triggered by the depletion of specific trophic factors, such as the withdrawal of interleukin-3 from hematopoietic cells. In fact, secreted 24p3 can induce apoptosis upon the withdrawal of interleukin-3 (Devireddy et al., 2001) . For the first time, Devireddy and colleagues (2005) describe a mechanism by which mouse 24p3 donates iron to cells and prevents apoptosis ( Figure 1A) . The authors suggest that the effects of 24p3 are dependent upon whether this protein contains iron or not. Bound to the holo form of 24p3 is the iron complex of the bacterial siderophore, enterobactin, whereas the apo form does not contain this complex. Interestingly, the receptor for 24p3, 24p3R, is reported to bind to both apo-and holo-24p3 and enables their internalization by endocytosis (Figure 1) .
The 24p3R mediates the ability of the holo-form of 24p3 to donate iron to cells and prevent apoptosis ( Figure 1A ). In contrast, the internalization of apo-24p3 by cells leads to iron efflux that results in apoptosis and cell death, which is mediated by the proapoptotic protein Bim ( Figure  1B) . Hence, the effect of apo-24p3 is reminiscent of the action of cytotoxic iron chelators, which bind to iron and induce apoptosis (Richardson, 2005) . The authors suggest a model in which internalized apo-24p3 binds to iron within the cell from a hypothetical mammalian siderophore. The holo24p3 that is subsequently generated is then released by exocytosis (Devireddy et al., 2005) .
Although the mechanism of uptake of holo-24p3 by 24p3R is reminiscent of the uptake of iron from holo-transferrin by the TfR1 (Richardson, 2005) , there are also some distinct differences. The uptake of transferrin by the TfR1 is largely dependent on the iron status of the protein-the affinity of TfR1 for holo-transferrin is far greater than its affinity for apo-trans- Devireddy et al., 2005) . Internalization of 24p3 and its receptor leads to the uptake of iron from the siderophore-iron complex. Although the exact mechanism remains unclear, Yang et al. (2002) describe a process that requires acidification of an endosomal-like compartment and the potential transport of the released iron via the DMT1. Donation of iron to the cell leads to a decrease in TfR1 expression and an increase in ferritin levels (Richardson, 2005) . In addition, donation of iron to the cell prevents apoptosis by decreasing the expression of the proapoptotic protein Bim. (B) Apo-24p3 binds to 24p3R and is internalized into the cell. However, it is not known whether this route is different from that taken by holo-24p3. Devireddy and colleagues (2005) suggest that a putative intracellular mammalian "siderophore" iron complex becomes bound to apo-24p3 to form holo-24p3, which is subsequently released from the cell by exocytosis. Depletion of iron from the cell results in the upregulation of the proapoptotic molecule, Bim, which leads to apoptosis. The putative intracellular mammalian siderophore has not yet been characterized and remains speculative.
ferrin (Richardson, 2005) . In contrast, although the affinity of 24p3R for apo-and holo-24p3 was not measured, Devireddy et al. (2005) indicate that both apo-and holo-24p3 can be bound and internalized by 24p3R, but each results in dramatically different biological consequences ( Figures  1A and 1B) . At present, it is unclear whether apo-and holo-24p3 bound to the 24p3R are sorted along the same intracellular trafficking pathway. The apo-24p3 that is generated when holo-24p3 donates its iron for metabolism would be expected to undergo exocytosis ( Figure 1A ). Yet, it is unclear whether this occurs. Presumably the apo form would be receptive to the iron-donating properties of the putative intracellular mammalian siderophore. Interestingly, a previous study did suggest that 24p3 was recycled after donating iron to the cell (Yang et al., 2002) . Further studies are needed to determine whether holo-and apo24p3 compete for 24p3R binding and whether they follow similar or different intracellular trafficking routes.
Surprisingly, Devireddy and colleagues (2005) also present evidence indicating that the BCR-ABL oncoprotein increases expression of apo-NGAL (the human homolog of 24p3) and at the same time represses the expression of its receptor (NGALR), resulting in cells that are unresponsive to secreted apo-NGAL. Treatment of cells with the BCR-ABL inhibitor, imatinib, resulted in upregulation of the NGALR, thereby rendering the cells sensitive to apo-NGAL-mediated apoptosis. This suggests a mechanism for how imatinib mediates apoptosis in cells that express BCR-ABL. The effect of imatinib was prevented by the addition of iron or holo-transferrin, which decreased Bim expression, thereby linking the pathways of iron metabolism and apoptosis. These results may be relevant to the treatment of chronic myelogenous leukemia (CML) with imatinib. Leukemic lymphoblasts from a limited number of untreated CML patients were shown to express high levels of apo-NGAL but not NGALR, whereas normal peripheral blood lymphocytes express high levels of the NGALR but only low levels of apo-NGAL (Devireddy et al., 2005) . The authors suggest that the secretion of apo-NGAL from BCR-ABL-expressing leukemic lymphoblasts may contribute to the severity and progression of CML by interfering with normal hematopoiesis. However, further studies are necessary to confirm this hypothesis.
While the study by Devireddy et al. (2005) is intriguing and provides a basis for further experimentation, there are some vital caveats that need to be discussed. First, the 24p3 iron uptake pathway is not essential for organogenesis or development, as deletion of this gene results in viable adult mice (Flo et al., 2004) . Second, the mammalian "siderophore" that potentially binds to apo-24p3 and is involved in iron efflux ( Figure 1B) has not been identified. Although there have been reports of siderophore-like growth factors from transformed cells (Fernandez-Pol, 1978) and normal tissues (Jones et al., 1980) , these findings remain isolated and unconfirmed. Moreover, there is no evidence of large quantities of low-molecularweight iron within mammalian cells that would be available to bind to apo24p3 (Richardson, 2005) . Third, Devireddy and colleagues (2005) have used 24p3 loaded with iron bound to the bacterial siderophore, enterobactin, to investigate iron uptake by mammalian cells. Although the 24p3-siderophore complex has relevance to the pathological state of bacteremia (Flo et al., 2004) , it is not relevant to physiological conditions such as early embryonic development, where prokaryotic siderophores are absent.
The iron uptake process reported by Devireddy and associates (2005) may be representative of a clearance mechanism that leads to the uptake and metabolism of bacterial siderophores bound to 24p3, but its relevance to normal cellular physiology remains unclear. The challenge for further studies is to isolate the putative mammalian siderophore, to determine whether 24p3 represents a physiologically-relevant mechanism of iron uptake, and to confirm its membership in the new iron age.
